UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549

NOTICE OF EFFECTIVENESS

Effective Date:July 17,
InflaRx NV (NASDAQ:IFRX)
Historical Stock Chart
From Apr 2024 to May 2024 Click Here for more InflaRx NV Charts.
InflaRx NV (NASDAQ:IFRX)
Historical Stock Chart
From May 2023 to May 2024 Click Here for more InflaRx NV Charts.

Inflarx N.v. News

InflaRx to Host Virtual R&D Event on June 5, 2024 and Report First Quarter 2024 Results on May 8, 2024
Tuesday 30 April 2024 (5 days ago) • GlobeNewswire Inc.
InflaRx to Participate in Capital One Securities 1st Annual Biotech/Biopharma Disrupters Event
Wednesday 24 April 2024 (2 weeks ago) • GlobeNewswire Inc.
InflaRx Reports Full Year 2023 Results and Announces INF904 Development Plans
Thursday 21 March 2024 (1 month ago) • GlobeNewswire Inc.
InflaRx to Announce Development Plans for INF904 and 2023 Financial Results on March 21, 2024
Tuesday 19 March 2024 (2 months ago) • GlobeNewswire Inc.
InflaRx Appoints Jan Medina as Head of Investor Relations
Thursday 22 February 2024 (2 months ago) • GlobeNewswire Inc.
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
Friday 26 January 2024 (3 months ago) • Edgar (US Regulatory)
InflaRx Announces Initiation of its Commitment Program for GOHIBIC®(vilobelimab) to Help Broaden Access for Eligible Patients
Thursday 25 January 2024 (3 months ago) • GlobeNewswire Inc.
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
Friday 5 January 2024 (4 months ago) • Edgar (US Regulatory)
InflaRx Announces Positive Topline Results from the Multiple Ascending Dose (MAD) Phase I Study with C5aR Inhibitor INF904
Thursday 4 January 2024 (4 months ago) • GlobeNewswire Inc.
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
Tuesday 7 November 2023 (6 months ago) • Edgar (US Regulatory)
InflaRx Announces First Patient Dosed in Phase III Trial with Vilobelimab in Pyoderma Gangrenosum
Monday 6 November 2023 (6 months ago) • GlobeNewswire Inc.
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
Wednesday 1 November 2023 (6 months ago) • Edgar (US Regulatory)

More Inflarx N.v. News Articles